Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

NCT01273155 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Lymphomas

Interventions

DRUG: Belinostat

Sponsor

National Cancer Institute (NCI)